Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 1No longer available 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Endocrine 1

Conditions

Insulinoma 2Hypoglycemia 2Hyperinsulinism 2Glioma 2Congenital Hyperinsulinism 2Brain Neoplasms 2Pheochromocytoma 1Parkinson Disease 1Neuroendocrine Tumors 1Neuroblastoma 1Lewy Body Disease 1Infant, Newborn, Diseases 1Glucose Metabolism Disorders 1Endocrine System Diseases 1Carcinoid Tumor 1

Interventions

gallium Ga 68 dotatate 4lutetium Lu 177 dotatate 2belzutifan 2Fluorodeoxyglucose F18 23-fluorobenzylguanidine 2olaparib 1fluorodopa F 18 1fludarabine phosphate 1Specimen Handling 1Phenoxybenzamine 1Magnetic Resonance Spectroscopy 1Interleukin-13 1Genetic Testing 1Cyclophosphamide 1Blood Specimen Collection 1Biopsy 16-fluorodopamine 13-Iodobenzylguanidine 1177Lu-octreotide, DOTA(0)-Tyr(3)- 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Pheochromocytoma × fluorodopa F 18 × Clear all
NCT00004847 2026-06-03

Diagnosis of Pheochromocytoma

National Institutes of Health Clinical Center (CC)

Phase 1 Recruiting
3,000 enrolled
Endocrine

Endocrine System Diseases, Pheochromocytoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡